Atai Life Sciences SG&A Expenses 2020-2024 | ATAI
Atai Life Sciences sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Atai Life Sciences Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $64 |
| 2022 | $70 |
| 2021 | $93 |
| 2020 | $81 |
| 2019 | $5 |
| Atai Life Sciences Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | $13 |
| 2024-03-31 | $13 |
| 2023-12-31 | $19 |
| 2023-09-30 | $14 |
| 2023-06-30 | $17 |
| 2023-03-31 | $14 |
| 2022-12-31 | $16 |
| 2022-09-30 | $19 |
| 2022-06-30 | $17 |
| 2022-03-31 | $18 |
| 2021-12-31 | $26 |
| 2021-09-30 | $20 |
| 2021-06-30 | $37 |
| 2021-03-31 | $9 |
| 2020-12-31 | $72 |
| 2020-09-30 | $4 |
| 2020-06-30 | $3 |
| 2020-03-31 | $2 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.237B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.419B | 12.35 |
| Quest Diagnostics (DGX) | United States | $17.788B | 18.03 |
| DaVita (DVA) | United States | $12.272B | 15.87 |
| Encompass Health (EHC) | United States | $10.397B | 24.51 |
| Chemed (CHE) | United States | $8.402B | 25.82 |
| Elanco Animal Health (ELAN) | United States | $6.955B | 16.55 |
| RadNet (RDNT) | United States | $5.364B | 127.25 |
| Option Care Health (OPCH) | United States | $3.826B | 18.13 |
| Amedisys (AMED) | United States | $3.166B | 22.54 |
| LifeStance Health (LFST) | United States | $2.816B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.313B | 27.14 |
| Astrana Health (ASTH) | United States | $2.305B | 36.12 |
| U.S Physical Therapy (USPH) | United States | $1.434B | 37.73 |
| Pennant (PNTG) | United States | $1.148B | 46.42 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.127B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.014B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.011B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |